NeuralRegen

At the March 26, 2026, Morning Edition event at Catalyst Omaha, Howard Gendelman, MD—Chair of UNMC’s Department of Pharmacology and Experimental Neuroscience and Chief Science Officer at his startup, NeuralRegen—delivers a short presentation about the innovative therapies he and his company are developing for treating neurodegenerative diseases.

Milk could key next-generation treatments for AD, PD

March 31, 2026

OMAHA, Nebraska (March 26, 2026)—Howard Gendelman, MD, one of UNMC’s most...

Read article

Gendelman to lead next Idea Pub: Morning Edition

March 9, 2026

OMAHA, Nebraska (March 9, 2026)—Prolific UNMC innovator Howard Gendelman, MD,...

Read article